GATA3 staining, though focal and variable, has been reported in ChrRCC, as well as in a small subset of ROs from a pan-tumor immunohistochemical study [53]; nevertheless, since this study dates back to 10 years ago, it has been suggested that at least some of the cases diagnosed as ChrRCC and RO at that time, if reviewed today, would be reclassified into other diagnostic categories within the spectrum of oncocytic tumors, including the LOT [34]. Here, GATA3 is linked to neoplasm.